- Home
- RCKT vs NRC Comparison
RCKT vs NRC Comparison
Compare RCKT & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | NRC |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 390.8M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | RCKT | NRC |
|---|---|---|
| Price | $3.65 | $16.91 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.73 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 72.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.81% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $69.83 | N/A |
| P/E Ratio | ★ N/A | $0.34 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $2.19 | $9.76 |
| 52 Week High | $8.26 | $22.79 |
Technical Indicators
Market Signals| Indicator | RCKT | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 53.52 |
| Support Level | $2.99 | $16.64 |
| Resistance Level | $4.08 | $18.29 |
| Average True Range (ATR) | 0.32 | 0.74 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 17.83 | 45.79 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.